Please ensure Javascript is enabled for purposes of website accessibility

Steve Jobs Isn't Leaving Apple

By Tim Beyers – Updated Apr 6, 2017 at 2:22AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Eat that, rumormongers.

Steve Jobs isn't at 100%, but won't be leaving Apple (NASDAQ:AAPL).

In an open letter to the Mac faithful issued today, Jobs said that doctors have diagnosed a hormone imbalance that's robbing his body of protein and causing the noticeable weight loss that made headlines in 2008.

"The remedy for this nutritional problem is relatively simple and straightforward, and I've already begun treatment. But, just like I didn't lose this much weight and body mass in a week or a month, my doctors expect it will take me until late this Spring to regain it. I will continue as Apple's CEO during my recovery," Jobs wrote.

No doubt some will be skeptical. Not me. My eldest son has a combination of food allergies and celiac disease, which, as with Jobs, prevents his body from absorbing most proteins. There's no cure, but specialized foods ensure that he remains healthy.

But most people don't fully comprehend my son's predicament. Those who do have spent considerable time talking with us about what he can and can't eat. It makes me wonder whether Jobs' PR campaign has just begun.

CIO magazine contributor Rich Levin, a tech watcher who's also an old friend, says that's a good idea. "Good move on his part, PR wise. Now they should serve up some specifics so experts can comment and bring calm to investors," he wrote.

I agree. Apple needn't comment further, but having experts explain what Jobs faces and what the risks are would eliminate needless uncertainty. Jobs, for his part, says that he's done commenting. "So now I've said more than I wanted to say, and all that I am going to say, about this," he wrote.

I understand. Jobs' health is his business. Were he in danger of not being able to run Apple then, yes, we'd have a right to know. Barring that, the man has a right to privacy.

But those demanding full disclosure -- and there are many -- argue, rightly, that Jobs is more valuable to Apple than Mike Dell is to Dell (NASDAQ:DELL) or Mark Hurd is to Hewlett-Packard (NYSE:HPQ).

Plus, there's no obvious successor to Jobs. Bill Gates had Steve Ballmer for Microsoft (NASDAQ:MSFT). Google (NASDAQ:GOOG) has Larry, Sergey, and CEO Eric Schmidt. Who'll succeed Jobs? Marketing chief Phil Schiller? Not if the Mac faithful have a say.

Steve won't be leaving Apple soon. But he will someday. Until there's a succession plan in place -- one we all know and like -- this issue isn't going away.

For related Foolishness:

Apple is a Stock Advisor selection. Google is a Rule Breakers recommendation. Microsoft and Dell are Inside Value picks. Try any of these Foolish services free for 30 days. There's no obligation to subscribe.

Fool contributor Tim Beyers wishes there was a cure for celiac. He had stock and options positions in Apple and Google at the time of publication.

Check out Tim's portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. The Motley Fool is also on Twitter as @TheMotleyFool. Its disclosure policy is 15 years young.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$150.77 (0.23%) $0.34
HP Inc. Stock Quote
HP Inc.
HPQ
$24.96 (-1.54%) $0.39
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.45 (-0.20%) $0.47
Alphabet Inc. Stock Quote
Alphabet Inc.
GOOGL
$98.17 (-0.58%) $0.57
Dell Technologies Inc. Stock Quote
Dell Technologies Inc.
DELL.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.